Journey Strategic Wealth’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,157
Closed -$71.2K 829
2025
Q4
$71.2K Buy
+25,157
New +$130K ﹤0.01% 753
2025
Q2
Sell
-17,596
Closed -$112K 664
2025
Q1
$112K Buy
17,596
+2,596
+17% +$25K ﹤0.01% 490
2024
Q4
$178K Buy
+15,000
New +$256K 0.01% 474
2024
Q2
Sell
-15,000
Closed -$264K 400
2024
Q1
$264K Buy
+15,000
New +$221K 0.01% 214
2023
Q2
Sell
-67,000
Closed -$499K 209
2023
Q1
$499K Buy
+67,000
New +$666K 0.05% 102

Other funds holding ASPN

Journey Strategic Wealth's ASPN Position: Q1 2026 in Review

Journey Strategic Wealth sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 25,157 shares — an estimated $71.2K sold.

Journey Strategic Wealth first reported a position in ASPN in Q1 2023 and held it in 5 quarters. The position peaked at $499K in Q1 2023. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Journey Strategic Wealth reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Journey Strategic Wealth sold 25,157 Aspen Aerogels shares in Q1 2026, an estimated $71.2K.
  • Journey Strategic Wealth first reported a position in Aspen Aerogels in Q1 2023 and held it in 5 quarters.
  • Journey Strategic Wealth's Aspen Aerogels position peaked at $499K in Q1 2023.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.